LUKE EVNIN Insider Trading Transactions
Get free email notifications about insider trading for LUKE EVNIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKE EVNIN. LUKE EVNIN is 10% Owner in VIACELL INC ($VIAC) and in CORNERSTONE THERAPEUTICS INC ($CRTX) and Director in METABASIS THERAPEUTICS INC ($MBRX) and in Pharmasset Inc ($VRUS) and 10% Owner in Pharmasset Inc ($VRUS) and 10% Owner in Pernix Sleep, Inc. ($SOMX) and in Omrix Biopharmaceuticals, Inc. ($OMRI) and 10% Owner in Omrix Biopharmaceuticals, Inc. ($OMRI) and Director in Restore Medical, Inc. ($REST) and 10% Owner in Conatus Pharmaceuticals Inc. ($CNAT) and Director in Pacira Pharmaceuticals, Inc. ($PCRX) and 10% Owner in Radius Health, Inc. ($RDUS) and 10% Owner in Epizyme, Inc. ($EPZM).
Latest Insider Trading Transactions of LUKE EVNIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRTX, EPZM, HSTO, MBRX, OMRI, PCRX, SOMX, VRUS, RDUS, REST, VIAC
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 162,813 | 0 | 0 | |
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 53,331 | 0 | 0 | |
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 402,115 | 0 | 0 | |
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 384,261 | 0 | 0 | |
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Buy | J | 0.00 | 1,088,251 | 0 | 5,831,253 | 4.7 M to 5.8 M (+22.94 %) |
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 714,095 | 0 | 4,743,002 | 4 M to 4.7 M (+17.72 %) |
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 255,881 | 0 | 4,028,907 | 3.8 M to 4 M (+6.78 %) |
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 1,929,344 | 0 | 3,773,026 | 1.8 M to 3.8 M (+104.65 %) |
Jun 10 2014 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 1,843,682 | 0 | 1,843,682 | 0 to 1.8 M |
Feb 11 2014 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 29.25 | 466,666 | 13,649,981 | 2,413,819 | 2.9 M to 2.4 M (-16.20 %) |
Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 7.43 | 32,220 | 239,395 | 32,220 | |
Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.90 | 265,837 | 239,253 | 0 | |
Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 8,333,334 | 0 | 0 | |
Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Buy | P | 11.00 | 165,265 | 1,817,915 | 1,192,080 | 1 M to 1.2 M (+16.09 %) |
Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Buy | J | 11.00 | 16,716 | 183,876 | 1,026,815 | 1 M to 1 M (+1.65 %) |
Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 1,010,099 | 0 | 1,010,099 | 0 to 1 M |
Apr 30 2013 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Option Exercise | P | 6.14 | 407,034 | 2,500,003 | 0 | |
Apr 30 2013 | RDUS | Radius Health, Inc ... | EVNIN LUKE | 10% Owner | Option Exercise | P | 0.00 | 162,813 | 0 | 0 | |
Jun 13 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | A | 29.90 | 7,000 | 209,300 | 7,000 | |
Jun 13 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.07 | 20,311 | 610,843 | 0 | 20.3 K to 0 (-100.00 %) |
Jun 13 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 2,435 | 73,050 | 20,311 | 22.7 K to 20.3 K (-10.71 %) |
Jun 04 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 82,072 | 2,462,160 | 824,255 | 906.3 K to 824.3 K (-9.06 %) |
Jun 03 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 9,935 | 298,050 | 906,327 | 916.3 K to 906.3 K (-1.08 %) |
Jun 03 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 44,582 | 1,337,460 | 916,262 | 960.8 K to 916.3 K (-4.64 %) |
May 30 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 20,411 | 612,330 | 960,844 | 981.3 K to 960.8 K (-2.08 %) |
May 30 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 32.14 | 5,300 | 170,342 | 981,255 | 986.6 K to 981.3 K (-0.54 %) |
May 30 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 31.38 | 74,980 | 2,352,872 | 986,555 | 1.1 M to 986.6 K (-7.06 %) |
May 30 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.62 | 114,837 | 3,516,309 | 1,061,535 | 1.2 M to 1.1 M (-9.76 %) |
May 23 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 7,340 | 220,200 | 1,176,372 | 1.2 M to 1.2 M (-0.62 %) |
May 21 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 13,550 | 406,500 | 1,183,712 | 1.2 M to 1.2 M (-1.13 %) |
May 08 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | X | 2.69 | 37,192 | 100,046 | 0 | |
May 08 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 29.30 | 3,416 | 100,089 | 1,314,255 | 1.3 M to 1.3 M (-0.26 %) |
May 08 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | X | 2.69 | 37,192 | 100,046 | 1,317,671 | 1.3 M to 1.3 M (+2.90 %) |
Apr 29 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.04 | 6,303 | 189,342 | 1,163,486 | 1.2 M to 1.2 M (-0.54 %) |
Apr 29 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 108,115 | 3,243,450 | 1,169,789 | 1.3 M to 1.2 M (-8.46 %) |
Apr 18 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 2,575 | 77,250 | 1,277,904 | 1.3 M to 1.3 M (-0.20 %) |
Apr 18 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 30.00 | 10,000 | 300,000 | 1,280,479 | 1.3 M to 1.3 M (-0.77 %) |
Jun 06 2013 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 1,176,472 | 0 | 0 | |
Jun 06 2013 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 6,930,000 | 0 | 0 | |
Jun 06 2013 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 392,156 | 0 | 2,880,485 | 2.5 M to 2.9 M (+15.76 %) |
Jun 06 2013 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 2,309,998 | 0 | 2,488,329 | 178.3 K to 2.5 M (+1,295.34 %) |
Mar 19 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 28.44 | 500,000 | 14,220,000 | 2,290,479 | 2.8 M to 2.3 M (-17.92 %) |
Mar 13 2013 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Sell | S | 27.86 | 500,000 | 13,930,000 | 2,790,479 | 3.3 M to 2.8 M (-15.20 %) |
Jul 10 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.31 | 1,624,574 | 498,744 | 1,275,886 | 2.9 M to 1.3 M (-56.01 %) |
Jul 10 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.29 | 671,217 | 195,324 | 2,900,460 | 3.6 M to 2.9 M (-18.79 %) |
Jul 05 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.29 | 98,210 | 28,481 | 3,571,677 | 3.7 M to 3.6 M (-2.68 %) |
Jul 05 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.29 | 80,348 | 23,301 | 3,669,887 | 3.8 M to 3.7 M (-2.14 %) |
Jul 02 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.29 | 19,500 | 5,655 | 3,750,235 | 3.8 M to 3.8 M (-0.52 %) |
Jun 21 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.29 | 12,000 | 3,480 | 3,759,735 | 3.8 M to 3.8 M (-0.32 %) |
Jun 19 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.29 | 1,450 | 421 | 3,781,735 | 3.8 M to 3.8 M (-0.04 %) |
Jun 07 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.29 | 8,400 | 2,436 | 3,783,185 | 3.8 M to 3.8 M (-0.22 %) |
Jun 07 2012 | SOMX | Pernix Sleep, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 0.29 | 29,555 | 8,571 | 3,791,585 | 3.8 M to 3.8 M (-0.77 %) |
Jun 06 2012 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | A | 10.81 | 7,000 | 75,670 | 7,000 | |
Nov 22 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | P | 6.50 | 461,538 | 2,999,997 | 3,290,479 | 2.8 M to 3.3 M (+16.31 %) |
Jun 06 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | A | 13.98 | 15,692 | 219,374 | 15,692 | |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 13.44 | 712,567 | 9,576,900 | 0 | |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 1,487,680 | 0 | 0 | |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | P | 7.00 | 267,857 | 1,874,999 | 2,828,941 | 2.6 M to 2.8 M (+10.46 %) |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | P | 7.00 | 267,857 | 1,874,999 | 2,561,084 | 2.3 M to 2.6 M (+11.68 %) |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 712,567 | 0 | 2,293,227 | 1.6 M to 2.3 M (+45.08 %) |
Feb 10 2011 | PCRX | Pacira Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,487,680 | 0 | 1,580,660 | 93 K to 1.6 M (+1,600.00 %) |
Jan 29 2010 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Sell | D | 0.00 | 4,814,725 | 0 | 0 | 4.8 M to 0 (-100.00 %) |
Jul 22 2008 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Option Exercise | D | 0.02 | 312,333 | 6,247 | 0 | |
Jul 22 2008 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Sell | D | 0.00 | 3,979,078 | 0 | 0 | 4 M to 0 (-100.00 %) |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 20.10 | 9 | 181 | 2,089,394 | 2.1 M to 2.1 M (0.00 %) | |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 20.06 | 300 | 6,018 | 2,089,403 | 2.1 M to 2.1 M (-0.01 %) | |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 20.00 | 200 | 4,000 | 2,089,703 | 2.1 M to 2.1 M (-0.01 %) | |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.97 | 400 | 7,988 | 2,089,903 | 2.1 M to 2.1 M (-0.02 %) | |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.94 | 100 | 1,994 | 2,090,303 | 2.1 M to 2.1 M (0.00 %) | |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.93 | 1,628 | 32,446 | 2,090,403 | 2.1 M to 2.1 M (-0.08 %) | |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.92 | 100 | 1,992 | 2,092,031 | 2.1 M to 2.1 M (0.00 %) | |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.91 | 100 | 1,991 | 2,092,131 | 2.1 M to 2.1 M (0.00 %) | |
Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.90 | 26,100 | 519,390 | 2,092,231 | 2.1 M to 2.1 M (-1.23 %) | |
Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 20.00 | 1,400 | 28,000 | 2,118,331 | 2.1 M to 2.1 M (-0.07 %) |
Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 19.94 | 100 | 1,994 | 2,119,731 | 2.1 M to 2.1 M (0.00 %) |
Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 19.92 | 100 | 1,992 | 2,119,831 | 2.1 M to 2.1 M (0.00 %) |
Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 19.91 | 500 | 9,955 | 2,119,931 | 2.1 M to 2.1 M (-0.02 %) |
Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 19.90 | 153,700 | 3,058,630 | 2,120,431 | 2.3 M to 2.1 M (-6.76 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | P | 2.69 | 70,538 | 189,747 | 70,538 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | X | 2.34 | 244,881 | 573,022 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | J | 2.34 | 244,881 | 573,022 | 244,881 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | J | 6.74 | 244,881 | 1,650,498 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | P | 2.34 | 71,866 | 168,166 | 4,814,725 | 4.7 M to 4.8 M (+1.52 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | X | 2.34 | 244,881 | 573,022 | 4,742,859 | 4.5 M to 4.7 M (+5.44 %) |
Nov 20 2007 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Sell | U | 7.25 | 41,146 | 298,309 | 0 | 41.1 K to 0 (-100.00 %) |
Nov 20 2007 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Sell | U | 7.25 | 2,715 | 19,684 | 0 | 2.7 K to 0 (-100.00 %) |
Nov 20 2007 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Sell | U | 7.25 | 46,089 | 334,145 | 0 | 46.1 K to 0 (-100.00 %) |
Nov 20 2007 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Sell | U | 7.25 | 130,880 | 948,880 | 0 | 130.9 K to 0 (-100.00 %) |
Nov 20 2007 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Sell | U | 7.25 | 14,444 | 104,719 | 0 | 14.4 K to 0 (-100.00 %) |
Nov 20 2007 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Sell | U | 7.25 | 25,283 | 183,302 | 0 | 25.3 K to 0 (-100.00 %) |
Nov 20 2007 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Sell | U | 7.25 | 335,628 | 2,433,303 | 0 | 335.6 K to 0 (-100.00 %) |
Nov 20 2007 | VIAC | VIACELL INC | EVNIN LUKE | 10% Owner | Sell | U | 7.25 | 5,012,274 | 36,338,987 | 0 | 5 M to 0 (-100.00 %) |
Feb 15 2007 | CRTX | CORNERSTONE THERAP ... | EVNIN LUKE | Buy | J | 0.00 | 7,226 | 0 | 7,226 | 0 to 7.2 K | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | Buy | J | 0.00 | 60,640 | 0 | 60,640 | 0 to 60.6 K | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | Sell | J | 0.00 | 1,567,823 | 0 | 0 | 1.6 M to 0 (-100.00 %) | |
Oct 25 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Gift | G | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Oct 25 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Sell | S | 19.76 | 21,402 | 422,829 | 10,000 | 31.4 K to 10 K (-68.15 %) |
Oct 25 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Sell | S | 19.95 | 30,483 | 608,136 | 31,402 | 61.9 K to 31.4 K (-49.26 %) |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Buy | J | 0.00 | 61,885 | 0 | 61,885 | 0 to 61.9 K |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Sell | J | 0.00 | 1,600,000 | 0 | 1,567,823 | 3.2 M to 1.6 M (-50.51 %) |
May 24 2006 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Option Exercise | C | 3.48 | 143,673 | 499,982 | 143,673 | |
May 24 2006 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Option Exercise | C | 2.62 | 190,835 | 499,988 | 0 | |
May 24 2006 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 2,048,731 | 0 | 0 | |
May 24 2006 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 763,359 | 0 | 0 | |
May 24 2006 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,542,436 | 0 | 3,979,083 | 2.4 M to 4 M (+63.30 %) |
May 24 2006 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Buy | C | 0.00 | 574,713 | 0 | 2,436,647 | 1.9 M to 2.4 M (+30.87 %) |
May 24 2006 | REST | Restore Medical, I ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,861,934 | 0 | 1,861,934 | 0 to 1.9 M |
Page: 1